TrialSurgery today2019

Phase II trial of induction chemotherapy with carboplatin and paclitaxel plus bevacizumab in patients with stage IIIA to IV nonsquamous non-small cell lung cancer.

Kazuhiro Imai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.